Back to Near-Term Bullish on SPX and QQQ We downgraded our near-term outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ) to neutral last week (11/19/25 Compass), after being bullish since our 4/22/25 Compass, while maintaining our intermediate-term bullish outlook (as of our 5/14/25 Compass). Crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ held last week, and we are right back to being near-term bullish as long as these support levels continue to hold. Just know that SPX could see...
Moody's Ratings (Moody's) assigned a Baa3 rating to the senior unsecured notes offering of Illumina, Inc. (Illumina). There are no changes to Illumina's existing ratings including the Baa3 senior unsecured notes, Baa3 issuer rating and (P)Baa3 senior unsecured shelf registration. The outlook is unch...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...
Two Directors at Illumina Inc bought 18,450 shares at between 80.864USD and 81.210USD. The significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Illumina, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 10 April 2025 in which we reassessed the appropriateness of the ratings in the context of th...
Moody's Ratings (Moody's) assigned a Baa3 rating to the new senior unsecured notes offering of Illumina, Inc. ("Illumina"). In addition, we assigned a (P)Baa3 rating to Illumina's new senior unsecured shelf registration statement. There are no changes to Illumina's existing Baa3 senior unsecured not...
Moody's Ratings (Moody's) affirmed the Baa3 issuer rating and senior unsecured ratings of Illumina, Inc. ("Illumina"). At the same time, Moody's revised the outlook to stable from negative. The revision of the outlook to stable reflects reduced negative pressure on Illumina's credit profile becaus...
Moody's Investors Service ("Moody's") has revised the outlook of Illumina, Inc. ("Illumina") to negative from stable. Concurrently, Moody's affirmed Illumina's Baa3 issuer and senior unsecured ratings. The revision of the outlook to negative reflects Moody's expectation that Illumina will operate ...
Moody's Investors Service, ("Moody's") assigned a Baa3 rating to the proposed offering of $1 billion of senior unsecured notes of Illumina, Inc ("Illumina"). There are no changes to Illumina's existing Baa3 issuer rating or the stable outlook. Proceeds of the offering will be used to repay upcomin...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.